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DNAmismatch repair (MMR) corrects mispaired DNA bases
and small insertion/deletion loops generated by DNA replica-
tion errors. After binding a mispair, the eukaryotic mispair rec-
ognition complex Msh2–Msh6 binds ATP in both of its nucle-
otide-binding sites, which induces a conformational change
resulting in the formation of anMsh2–Msh6 sliding clamp that
releases from themispair and slides freely along theDNA.How-
ever, the roles that Msh2–Msh6 sliding clamps play in MMR
remain poorly understood. Here, using Saccharomyces cerevi-
siae, we created Msh2 andMsh6Walker A nucleotide–binding
site mutants that have defects in ATP binding in one or both
nucleotide-binding sites of the Msh2–Msh6 heterodimer. We
found that these mutations cause a complete MMR defect in
vivo. ThemutantMsh2–Msh6 complexes exhibitednormalmis-
pair recognition and were proficient at recruiting the MMR
endonuclease Mlh1–Pms1 to mispaired DNA. At physiological
(2.5 mM) ATP concentration, the mutant complexes displayed
modest partial defects in supporting MMR in reconstituted
Mlh1–Pms1-independent and Mlh1–Pms1-dependent MMR
reactions in vitro and in activation of the Mlh1–Pms1 endonu-
clease and showed a more severe defect at low (0.1 mM) ATP
concentration. In contrast, five of the mutants were completely
defective and one was mostly defective for sliding clamp forma-
tion at high and lowATPconcentrations.These findings suggest
that mispair-dependent sliding clamp formation triggers bind-
ing of additional Msh2–Msh6 complexes and that further
recruitment of additional downstream MMR proteins is re-
quired for signal amplification ofmispair binding duringMMR.
DNA mismatch repair (MMR)2 is a conserved pathway that
repairs mispaired bases that result from errors during DNA
synthesis (1–6). MMR also acts on some forms of chemically
damaged DNA bases as well as on mispairs present in hetero-
duplex DNA intermediates formed during recombination
(1–6). MMR proteins also act in a pathway that suppresses
recombination between homologous but divergent DNAs
(1–6) and function in a DNA damage response pathway for
different types of DNA-damaging agents, including some che-
motherapeutic agents (2). As a result of the role thatMMRplays
in correcting mispairs, mutations in or loss of expression of
MMR genes results in increased mutation rates that underlie
both sporadic cancers and inherited cancer predisposition syn-
dromes in humans (7–11).
The initiation of MMR in eukaryotes relies upon the recog-
nition ofDNAmispairs by the partially redundantMsh2–Msh6
andMsh2–Msh3heterodimers, which are homologs of the bac-
terial MutS homodimer (1, 3, 12). Msh2–Msh6, Msh2–Msh3,
and MutS belong to the ABC family of ATPases and have two
composite nucleotide-binding sites at their dimeric interface
(13–17). Each composite nucleotide-binding site comprises the
Walker A and Walker B motifs from one subunit and the “sig-
nature” motif from the other subunit (18–20). In the MSH
complexes, of which Msh2–Msh6 has been the most exten-
sively studied, ATP binding, ATP hydrolysis, and ADP release
are intrinsically linked to conformational changes that play crit-
ical roles in MMR (20–34). In the Msh2–Msh6 complex, the
Msh6 subunit, which directly interacts with themispair, has the
higher affinity for ATP (10-fold higher than Msh2), whereas
theMsh2 subunit has the higher affinity forADP (24). Similarly,
the homodimeric bacterial MutS, which adopts an asymmetric
conformation upon mispair recognition (13, 14), also has ATP
binding asymmetries (25, 35, 36). In both human and Saccha-
romyces cerevisiae Msh2–Msh6, the Msh2 subunit controls
the cycle of ATP processing. After Msh2–Msh6 binds mis-
paired DNA, release of Mg2 from the Msh2 nucleotide-
binding site causes release of ADP from Msh2, which then
allows Msh6 to bind ATP (23, 24, 37). In turn, ATP binding
to the Msh6 nucleotide-binding site results in reduced affin-
ity of the Msh2 nucleotide-binding site for ADP, causing
Msh2 to favor binding of ATP (24). Msh2–Msh6 binding to
mispaired DNA also results in a reduction of the ATPase
activity of Msh6 (26).
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When Msh2–Msh6 and other members of the MutS family
of MMR proteins bind to mispaired bases, they form a ring
around the DNAwith the mispair recognition domain ofMsh6
(orMsh3 or themispair-binding subunit ofMutS)making con-
tactswith both themispair and adjacent sites on theDNA; these
contacts also result in bending of the DNA (13, 14, 16, 17, 38,
39). ATP binding by mispair-bound Msh2–Msh6 and other
MutS family members induces a number of conformational
changes in the protein complex: 1) the DNA mispair recogni-
tion domain and the connector domain become exposed (29,
40), and 2) upon binding ATP in both ATP-binding sites,
Msh2–Msh6 and other MutS family proteins transition into a
sliding clamp form that dissociates from the mispair, alleviates
theDNAbend at themispair, and slides along theDNA (22–24,
31–33, 38, 41–43). In addition, mispair and ATP binding by
Msh2–Msh6 results in recruitment of theMutL homolog com-
plexes Mlh1–Pms1 andMlh1–Mlh2 by the newly exposed sur-
faces on the connector domain of Msh2 (29, 40), which then
appears to allow loading of Mlh1–Pms1 and Mlh1–Mlh2 onto
the DNA and can mediate the formation of a MutL-based slid-
ing clamp (31, 41, 43–45).However, studies of dominantMSH6
mutant Msh2–Msh6 complexes have suggested that recruit-
ment of Mlh1–Pms1 by S. cerevisiae Msh2–Msh6 may not be
completely dependent on the formation ofMsh2–Msh6 sliding
clamps (21, 30).
Genetic studies of the Walker A and Walker B motifs have
provided evidence that ATP binding and hydrolysis are essen-
tial for Msh2–Msh6 function during MMR. Walker A muta-
tions that reduce ATP binding cause an MMR defect in
S. cerevisiae (46, 47). These mutations did not affect the recog-
nition of mispaired bases by Msh2–Msh6 in gel shift and filter
binding assays but did eliminate the ability of added ATP to
prevent the formation of Msh2–Msh6-mispaired DNA com-
plexes (46, 47). Mutations that result in amino acid substitu-
tions at the conserved Walker B Glu residue of S. cerevisiae
Msh2 and Msh6 that cause ATP hydrolysis defects similarly
resulted in MMR defects but did not affect either mispair rec-
ognition or ATP inhibition of formation of Msh2–Msh6-mis-
pairedDNAcomplexes as detected in gel shift assays (48). Stud-
ies of human MSH2–MSH6 have yielded somewhat different
results. Amino acid substitutions at the conserved Walker A
Lys residue of eitherMSH2orMSH6 resulted inmutant human
MSH2–MSH6 complexes that recognized mispaired bases in
gel shift assays, had ATP binding defects, showed partial resis-
tance to ATP inhibition of mispair binding, and caused partial
defects in the ability of MSH2–MSH6 to complement MMR-
defective extracts of HCT15 cells in MMR reactions in vitro
(49); the MSH2-Lys–MSH6-Lys double mutant protein had
more striking defects in the latter two assays (49). A more
recent study showed that Walker A Lys mutations affecting
human MSH2 or MSH6 resulted in MSH2–MSH6 complexes
that bound mispairs and exhibited ATP-induced dissociation
and partially defective formation of sliding clamps (37). In con-
trast, double Walker A Lys mutations were completely defec-
tive in ATP-dependent processes (37). In addition, a Walker B
Glu mutation in humanMSH6 was found to result in a mutant
humanMSH2–MSH6 complex that exhibited partial defects in
an extract-based MMR reaction in vitro and a partial defect in
ATP-dependent binding to an end-blocked mispaired DNA
substrate (50). Complementary experiments analyzing domi-
nant mutations that altered amino acids near the S. cerevisiae
Msh6 or Msh2 nucleotide-binding sites but did not affect key
catalytic amino acids have also provided evidence that ATP-
induced conformational changes of Msh2–Msh6 are critical to
MMR (21, 30, 51–54).
The studies performed to date have provided evidence that
the Msh2–Msh6 ATP processing cycle is important for MMR.
However, it is unclear how mutations affecting the Walker A
and B motifs result in MMR defects. Here, we mutated the
lysine codon (Lys694 in S. cerevisiae Msh2 and Lys988 in
S. cerevisiaeMsh6) in the Walker A motif to alanine, arginine,
or methionine codons, resulting in six mutant complexes, each
with one WT subunit and one mutant subunit. We examined
the mutations and resulting mutant Msh2–Msh6 complexes
using a battery of biochemical and genetic assays, many of
which have never been used to characterize Msh2–Msh6
Walker A mutants. These mutations caused complete MMR
defects in vivo and affected the ATP binding affinity of one or
both of the Msh2 and Msh6 nucleotide-binding sites. Consist-
ent with previous studies, none of these mutations altered mis-
pair recognition. Provided that ATP concentrations were high
enough to mitigate ATP binding defects of the Walker A Lys
mutant complexes, all of the mutant complexes supported
Mlh1–Pms1 recruitment to DNA, reconstituted MMR reac-
tions, and activation of mispair-dependent Mlh1–Pms1 endo-
nuclease activity to a large extent. In contrast, these mutant
complexes had a profound defect in forming sliding clamps
even at high ATP concentrations. Taken together, these data
are consistent with the hypothesis that sliding clamp formation
is required for MMR in vivo, most likely because mispair-de-
pendent accumulation of multiple Msh2–Msh6 complexes per
mispair is required for MMR.
Results
Msh2 andMsh6Walker Amutant complexes have defects in
ATP binding
WhenWTMsh2–Msh6 is bound to a mispair, ATP binding
at both the high- (Msh6) and low (Msh2)-affinity nucleotide-
binding sites triggers a conformational change from a relatively
static mispair recognition complex to a clamp that can slide
along the DNA (21–24, 32, 55). To study the role of ATP-in-
duced conformation changes during S. cerevisiae MMR, we
mutated the invariant lysine residue in the Walker A motif
(Msh2-Lys694 and Msh6-Lys988; Fig. 1A) to alanine, methio-
nine, or arginine, resulting in six mutant alleles: msh2-K694A,
msh2-K694M, msh2-K694R, msh6-K988A, msh6-K988M, and
msh6-K988R. This invariant lysine coordinates the -phos-
phate of bound ATP, and lysine to alanine or methionine
amino acid substitutions in related ATPases often prevents
ATP binding (24, 56), whereas lysine to arginine amino acid
substitutions often, but not always, result in mutants that
can bind, but not hydrolyze, ATP (56). For the sake of brev-
ity, we refer to these six mutations collectively as Walker A
Lys mutations/mutants.
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To assess the ability of the mutant complexes to bind ATP,
we utilized an assay where [-32P]ATP was bound to Msh2–
Msh6 under conditions where hydrolysis was inhibited (2.5mM
EDTA and no Mg2), ATP was cross-linked to the protein
usingUV irradiation, and sampleswere analyzed by SDS-PAGE
followed by autoradiography. In the case of the heterodimeric
Msh2–Msh6 complex, specific cross-linking to each subunit
can be visualized as Msh2 and Msh6 have different molecular
weights (21, 24, 57). TheATP concentrations usedwere chosen
to be modestly above the previously determined Kd values for
Msh2 (40 M) andMsh6 (0.3 M) (24), and ATP binding at
these concentrations was compared with WT Msh2–Msh6
(Fig. 1, B and C) (24). The Msh2(K694M)–Msh6 mutant com-
plex was only defective for binding ATP to the Msh2 subunit,
whereas the Msh2(K694A)–Msh6 and Msh2(K694R)–Msh6
mutant complexes were defective for ATP binding to both the
Msh2 and Msh6 subunits (Fig. 1, B and C). The Msh6 subunits
of each Msh6 mutant complex were defective for ATP binding
at 1 M ATP, whereas among the Msh6 mutant complexes the
Msh2–Msh6(K988A) and Msh2–Msh6(K988R) mutant com-
plexes had partial ATP binding defects at the Msh2 subunit at
60 M ATP (Fig. 1, B and C). Thus, all of the six mutant com-
plexes were defective for ATP binding to at least one subunit.
We separated the sixmutant complexes into two classes ofATP
binding alterations: 1) ATP binding defects in both subunits
(Msh2(K694A)–Msh6 and Msh2(K694R)–Msh6) and 2) ATP
binding defects in the mutated subunit with partial or no effect
on the other subunit (Msh2(K694M)–Msh6, Msh2–Msh6
(K988A), Msh2–Msh6(K988M), and Msh2–Msh6(K988R)).
Themsh2 andmsh6Walker Amotif mutations cause complete
MMR defects in vivo
To determine whether the Walker A Lys mutations affect
MMR in vivo, we integrated the mutations at the nativeMSH2
or MSH6 chromosomal loci as appropriate and tested their
effects on mutation rates in the hom3–10 and lys2–10A frame-
shift reversion rate assays and the CAN1 forward mutation
rate assay. The three Walker A Lys msh2 mutations caused
increasedmutation rates in all three assays that were equivalent
to those caused by anmsh2mutation, consistent with causing
a complete MMR defect (Table 1). Similarly, the three Walker
A Lys msh6 mutations caused increases in mutation rates that
were indistinguishable from the mutation rates caused by an
msh6 mutation (Table 1). Msh2–Msh6 and Msh2–Msh3 are
redundant in the repair of insertion/deletionmispairs (12), and
consistent with this, combining themsh6Walker A Lys muta-
tions with anmsh3mutation caused synergistically increased
mutation rates in the hom3–10 and lys2–10A frameshift rever-
sion rate assays and a modest increase in the CAN1 forward
mutation rate assay, resulting in mutation rates that were
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Figure 1. Effects ofmutations on the ability ofmutant subunits to bindATP.A, ATP-binding site from E. coliMutS (ProteinData Bank (PDB) code 5akb (29))
depicting highly conserved residues from the Walker A motif (Lys694 in S. cerevisiae Msh2 and Lys988 in S. cerevisiae Msh6) and their position relative to an
AMP-PNPATPanalog.B, histogramshowing relativeMsh2bindingof 60M [-32P]ATPunder nonhydrolyzable conditions.C, histogramshowing relativeMsh6
binding of 1 M [-32P]ATP under nonhydrolyzable conditions. Error bars represent the S.D. from the mean, and individual values from different experiments
are indicated by the dots on each histogram bar.
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equivalent to that caused by the msh2 single and msh3
msh6 doublemutations (Table 1). Previous studies that exam-
ined S. cerevisiae Walker A msh2 mutations on an ARS CEN
plasmid found that these mutant alleles did not complement
the mutator phenotype of an msh2 strain (46, 47). We con-
clude that the MSH2 and MSH6 Walker A Lys mutations are
complete loss-of-function mutations in vivo.
Themsh2 andmsh6Walker Amotif mutations are not
dominant
Agenetic screen for dominantmutations inMSH6 recovered
severalmsh6mutations that affected residues clustered around
the Msh6 ATPase site (51). These mutations cause large
increases in mutation rates, including increased frameshift
reversion rates when present as single mutations at theMSH6
locus and when present on a low-copy ARS CEN plasmid in an
otherwise WT strain (21, 30, 51, 52). Therefore, we tested
whether the Walker A Lys mutations were dominant alleles by
transforming low-copy number ARS CEN plasmids containing
the different MSH2 or MSH6 alleles into a WT strain. In con-
trast to the previously identified dominant mutations like
msh6-G1142D and msh6-S1036P (21, 30, 51, 52), none of the
plasmid-borne MSH2 or MSH6 Walker A Lys mutations
caused an increase in mutation rates in a WT strain and were
therefore not dominant to the chromosomally encodedMSH2
or MSH6 genes, respectively (Fig. S1). Previous analysis of the
Walker AGlymsh2mutations showed that thesemutations did
not cause an increasedmutation rate in aWT strain when pres-
ent on an ARS CEN plasmid (46, 47), which is consistent with
our results, but did cause a very small increase in mutation rate
when present in a heterozygous diploid S. cerevisiae strain.
These mutations and a Walker A Gly msh6 mutation were
dominant when overexpressed using a GAL10 promoter on a
high-copy-number 2-m plasmid (28, 46, 47). Our results and
those of others (28, 46, 47, 49) are most consistent withWalker
A mutations resulting in nonfunctional Msh2 or Msh6 pro-
teins. Therefore, overexpression of the nonfunctional Msh2
Walker A Gly mutant protein may inactivate MMR by seques-
tering all of theWTMsh6 andMsh3proteins in inactiveMsh2–
Msh6 and Msh2–Msh3 complexes, and overexpression of the
nonfunctional Msh6Walker A Gly mutant protein may inacti-
vate MMR by sequestering all of theWTMsh2 protein in inac-
tive Msh2–Msh6 complexes rather than blockingMMR due to
some type of gain-of-function defect similar to those caused by
dominant mutations likemsh6-G1142D andmsh6-S1036P (21,
30, 51, 52).
Msh2 andMsh6Walker Amotif Lysmutant complexes are
partially defective in reconstitutedMMR reactions in vitro
We next tested whether the Walker A Lys mutant Msh2–
Msh6 complexes could function in MMR reactions reconsti-
tuted in vitro with purified proteins and DNA substrates con-
taining a single thymine base insertion mispair on the same
strand as a pre-existing nick that is either 5 of themispair at the
NaeI site (5 repair assay) or 3 of themispair at theAflIII site (3
repair assay) (Fig. 2A). Nicked strand–specific mispair correc-
tion isMsh2–Msh6-dependent and restores a PstI site, which is
detected by restriction endonuclease digestion with both PstI
and ScaI, resulting in two repair-specific DNA species (Fig. 2B)
(58). The 5nick–directed repair reactions containATP,Mg2,
WT or mutantMsh2–Msh6, replication protein A, Exo1, DNA
polymerase , PCNA, RFC-1N (RFC-1N is an RFC1–5 com-
plex containing anN-terminal truncation of RFC1 that reduces
its DNAbinding but leaves all other functions intact (59); the 3
nick–directed repair assay reactions in addition contained
Mlh1–Pms1. Previous studies have demonstrated that the 5
nick–directed repair assay depends on Exo1 but does not
require Mlh1–Pms1 (53, 58, 60), whereas the 3 nick–directed
repair assay depends on Mlh1–Pms1 (53, 60) and under some
conditions can be at least partially independent of Exo1 (61).
We first investigated the ability of the Walker A Lys mutant
Msh2–Msh6 complexes to support repair in the 5 nick–
directed repair assay. In these reactions, Exo1 initiates excision
at the 5 nick in a reaction that is significantly stimulated by
Msh2–Msh6 in a mispair recognition–dependent fashion
resulting in excision of the mispair (58, 62). The resulting sin-
gle-stranded DNA gap is then filled in by DNA polymerase 
and accessory proteins; in addition,DNApolymerase  can sub-
stitute for DNA polymerase  (60). At concentrations of ATP
(2.5 mM) that exceed the Kd for ATP binding by both the Msh2
and Msh6 nucleotide-binding sites, the Walker A Lys mutant
Msh2–Msh6 complexes supported 40–75% of the level of
Table 1
Mutation rate analysis of msh2 andmsh6 ATPase mutations
Median rates of hom3–10 (Thr) and lys2–10A (Lys) reversion and inactivation of CAN1 (CanR) are shown. The 95% confidence intervals are reported in brackets, and
the -fold increases over wildtype are in parentheses.
Relevant genotype RDKY no. Thrmutation rate Lysmutation rate CanR mutation rate
Wildtype 5964 1.52 [1.22–3.30] 109 (1) 8.53 [6.67–18.6] 109 (1) 3.87 [3.56–8.53] 108 (1)
msh2 3688 6.74 [5.00–15.9] 106 (4,430) 8.04 [6.79–12.8] 105 (9,430) 5.87 [3.97–8.30] 106 (152)
msh2-K694A 9379 6.32 [5.64–10.8] 106 (4,160) 7.96 [5.95–14.2] 105 (9,330) 5.45 [4.42–7.81] 106 (141)
msh2-K694M 9381 9.22 [6.35–11.3] 106 (6,070) 1.30 [0.70–1.79] 104 (15,200) 4.85 [3.92–6.16] 106 (125)
msh2-K694R 9380 6.46 [4.94–10.8] 106 (4,250) 9.50 [7.74–12.7] 105 (11,100) 5.17 [3.78–5.96] 106 (134)
msh6 7965 2.61 [0.35–3.56] 108 (17.2) 9.04 [3.75–12.7] 107 (106) 1.36 [0.98–2.25] 106 (35.1)
msh6-K988A 9382 2.99 [1.86–6.12] 108 (19.7) 8.80 [6.79–12.5] 107 (103) 1.30 [0.94–1.97] 106 (33.6)
msh6-K988M 9384 1.57 [1.27–2.80] 108 (10.3) 1.47 [0.94–2.17] 106 (172) 1.23 [0.69–1.92] 106 (31.8)
msh6-K988R 9383 2.52 [1.78–4.81] 108 (16.5) 1.43 [1.07–1.94] 106 (168) 1.17 [9.54–16.3] 106 (30.2)
msh3a 4149 2.2 [1.6–3.5] 108 (14.5) 1.3 [0.87–1.9] 107 (15.2) 1.1 [0.5–1.3] 107 (2.8)
msh3msh6a 4234 3.1 [1.9–4.8] 106 (2,040) 4.8 [3.9–10.6] 105 (5,630) 3.1 [1.7–4.6] 106 (80.1)
msh3msh6-K988A 9385 3.65 [0.37–4.73] 106 (2,400) 6.99 [1.28–10.3] 105 (8,190) 2.56 [1.00–3.69] 106 (66.1)
msh3msh6-K988M 9387 5.04 [4.40–37.2] 106 (3,320) 9.48 [6.55–50.3] 105 (11,100) 3.60 [2.42–22.9] 106 (93.0)
msh3msh6-K988R 9386 4.79 [2.84–7.74] 106 (3,150) 9.23 [6.62–11.8] 105 (10,800) 2.48 [2.00–3.96] 106 (64.1)
a Rates from Shell et al. (78).
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repair supported byWTMsh2–Msh6 (Fig. 2, B and C). In con-
trast, all of these mutant complexes were completely defective
at low ATP concentrations (0.1 mM), which was still sufficient
for MMR supported by WT Msh2–Msh6 (Fig. 2D), albeit at a
somewhat reduced efficiency (17.8% of total DNA repaired at
0.1 mM ATP compared with 43.5% at 2.5 mM ATP).
We next investigated the ability of the Walker A Lys mutant
Msh2–Msh6 complexes to support repair in the 3 nick–
directed repair assay (53, 60, 63, 64). This reaction involves 1)
mispair recognition by Msh2–Msh6; 2) recruitment of Mlh1–
Pms1,which produces strand-specific nicks 5 of themispair on
the prenicked DNA strand; 3) excision of the mispair by Exo1
from theMlh1–Pms1-generated nicks; and 4) gap-filling resyn-
thesis by DNA polymerase  and accessory proteins. WithWT
Msh2–Msh6, these reactions resulted in repair of26% of the
3 nicked DNA substrate at high ATP concentrations (2.5 mM)
(Fig. 2E). In contrast, the substitution of the six Walker A
Lys mutant Msh2–Msh6 complexes for WT Msh2–Msh6
resulted in between 40 and 75% of WT levels of repair at 2.5
mM ATP (Fig. 2E). Reducing the ATP concentration to 0.1 mM
decreased the overall level of repair by WT Msh2–Msh6 to
13%. Interestingly, reactions containing Msh2(K694A)–
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Figure2.Msh2andMsh6mutants arepartiallydefective inan in vitro reconstitutedMMRassay.A, schematic representationof theDNAsubstrate for the
reconstituted repair assay. Substrates had a nick at either theNaeI or AflIII site but not both. B, representative gel showing repair of the 5nickedNaeI substrate
used in an assay with 2.5 mM ATP. C–F, the amount of repair relative to WTMsh2–Msh6 was quantitated for the 5 nicked NaeI substrate at 2.5 mM ATP (100%
repair43.5%of substrate repaired) (C), the5nickedNaeI substrate at 0.1mMATP (100%repair17.8%of substrate repaired) (D), the3nickedAflIII substrate
at 2.5mMATP (100% repair 23.2% of substrate repaired) (E), or the 3 nicked AflIII substrate at 0.1mMATP (100% repair 12.1% of substrate repaired) (F) by
normalizing the percentage of repair in each experiment to the WT levels and averaging a minimum of at least three independent experiments. Error bars
represent the S.D. from the mean, and individual values from different experiments are indicated by the dots on each histogram bar. In F, numbers over the
histogrambars are the averageof the ratio ofmutant repair to repairwithoutMsh2–Msh6 (compared internally betweenexperiments)with the error indicating
the S.D.
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Msh6, Msh2(K694R)–Msh6, and Msh2–Msh6(K988M) mutants
showed reduced levels of repair at 0.1 mM ATP that were pos-
sibly not above the background levels of repair observed in
the absence of Msh2–Msh6 (Fig. 2F). In contrast, reactions
containing Msh2(K694M)–Msh6, Msh2–Msh6(K988A), and
Msh2–Msh6(K988M) all resulted in low levels of repair at
0.1 mM ATP that were above background levels of repair
(Fig. 2F).
Because low ATP conditions (0.1 mM) eliminated 5 nick–
directed repair supported by all the Walker A Lys mutant
Msh2–Msh6 complexes (Fig. 2D) but did not completely elim-
inate Mlh1–Pms1–dependent 3 nick–directed repair sup-
ported by all theWalker A Lys mutantMsh2–Msh6 complexes
(Fig. 2F), we hypothesized that MMR under low ATP condi-
tions in reactions containing Mlh1–Pms1 might be indepen-
dent of Exo1. We therefore tested the 3 nick–directed repair
assay with and without Exo1. Consistent with the hypothesis
that repair in the 3 nick–directed repair assay under low ATP
conditions was Exo1-independent, the ratios of the percentage
of repair without Exo1 to the percentage of repair with Exo1
were 0.92 	 0.16, 0.97 	 0.08, and 1.23 	 0.13 for the WT
Msh2–Msh6 and Msh2(K694M)–Msh6 and Msh2–Msh6
(K988M)mutant complexes, respectively. That these ratios are
close to 1 suggests that absence of Exo1 does not reduce the
level of repair observed under these conditions. Together, these
results show that the six Walker A Lys mutant Msh2–Msh6
complexes are partially defective but largely functional for both
the 5 and 3 nick–directed repair at physiological ATP con-
centrations (2.5 mM ATP). However, they appear to be com-
pletely defective for Exo1-dependent repair at low ATP con-
centrations. Interestingly, the largely functional repair seen at
physiological ATP concentrations (2.5mMATP) contrasts with
the complete MMR defect exhibited by these mutant Msh2–
Msh6 complexes in vivo (Table 1).
TheWalker A LysmutantMsh2–Msh6 complexes are proficient
formispair binding
The ability of the Walker A Lys mutant Msh2–Msh6 com-
plexes to support reconstituted MMR reactions suggests that
these complexes can recognize mispair-containing DNA. To
directly assess mispair binding, we used surface plasmon reso-
nance (SPR) tomeasure the binding of themutant complexes to
236-bp dsDNAmolecules with andwithout a centralT inser-
tion mispair in the absence of ATP. DNA molecules were
immobilized at one end on a streptavidin-coated surface
through a 5-biotin located at the end of one of the two DNA
strands. Representative sensorgrams monitoring response
units (RU) of binding revealed that both WTMsh2–Msh6 and
Msh2–Msh6(K988M) complexes preferentially bound theT-
containing substrate relative to the control DNA lacking a mis-
pair and that both complexes had similar levels of binding (Fig.
3A). We determined the steady-state responses by fitting the
association curves (RUmax; see “Experimental procedures”). All
of theMsh2 andMsh6WalkerALysmutantMsh2–Msh6 com-
plexes exhibited levels of mispair binding that were the same as
that of WT Msh2–Msh6 (Fig. 3B), indicating that all of the
mutant complexes were proficient for mispair binding in the
absence of added nucleotides. Moreover, the Msh2(K694M)–
Msh6, Msh2–Msh6(K988A), and Msh2–Msh6(K988R) com-
plexes had modestly increased levels of binding to both mis-
paired and fully base-pairedDNAs relative toWTMsh2–Msh6
(Fig. 3B). These results are consistent with the results of previ-
ous experiments inwhichmispair binding by a limited subset of
Walker A and B mutant Msh2–Msh6 complexes was assessed
using gel shift and filter binding assays (28, 46–49).
Msh2 andMsh6Walker A Lysmutant complexes are defective
for sliding clamp formation
Mispair-bound Msh2–Msh6 is converted into a sliding
clamp after binding ATP in both the Msh2 and Msh6 nucle-
otide-binding sites (22–24, 32), and mutations in MSH2 and
MSH6 that result in Msh2–Msh6 complexes that cannot form
sliding clamps result inMMR defects (21, 30, 51). Formation of
ATP-dependent Msh2–Msh6 sliding clamps can be observed
in SPR experiments by comparing the level of binding ofMsh2–
Msh6 to mispair-containing DNAs that are blocked at either
one or both ends. Double end–blocked substrates allow a dra-
matic increase in RU due to a buildup of Msh2–Msh6 com-
plexes because sliding clamps slide away from the mispair but
remain trapped by the end blocks, allowing additional Msh2–
Msh6 complexes to bind to the mispair and form sliding
clamps. In contrast, Msh2–Msh6 sliding clamps slide off the
end of single end–blocked DNAs, and hence the single end–
blocked substrates do not accumulate large amounts of bound
Msh2–Msh6 complexes. Furthermore, if Msh2–Msh6 sliding
clamps accumulate on double end–blocked mispaired DNA
and one of the end blocks is released, the sliding clamps rapidly
dissociate from the DNA by sliding off the free DNA end, pro-
viding additional evidence for the formation of sliding clamps.
We have previously developed a system involving one stable
end block that immobilizes the 236-bp mispair-containing
DNA to the surface (biotin-streptavidin) and a proximal revers-
ible end block (lacO-LacI) (22). Thus, in the presence of ATP, a
dramatic increase in RU due to sliding clamp formation can be
observed on the double end–blocked substrate, whereas a rapid
decrease in RU is observed upon IPTG addition, which releases
the LacI end block and allows the majority of accumulated
Msh2–Msh6 complexes to slide off the substrate. Examples of
this type of SPR analysis for the WT Msh2–Msh6, the sliding
clamp–defective Msh2(K694M)–Msh6, and the partially slid-
ing clamp–defective Msh2–Msh6(K688M) complexes are
shown in Fig. 4A.
We first analyzed the steady-state binding ofMsh2–Msh6 on
double end–blockedmispairedDNA as a function of ATP con-
centration (Fig. 4B). WT Msh2–Msh6 showed a high level of
steady-state binding (RUmax) at the lowest ATP concentration
tested (0.1 mM), which was 
3-fold higher than the level of
binding in the absence of ATP, and a gradual increase in steady-
state binding up to the highest ATP concentration of 2.5 mM
(Fig. 4B). Because responses in SPR are proportional to bound
mass (65), we calculated the steady-state molar ratio of Msh2–
Msh6 at RUmax based on the initial RU response due to DNA.
For WTMsh2–Msh6, 2.4–3.3 complexes of WTMsh2–Msh6
complexes were bound per DNA molecule (Fig. 4C). In con-
trast, the Msh2–Msh6(G1142D) dominant mutant complex,
included as a control, was largely unaffected by ATP concen-
Msh2–Msh6 sliding clamps amplifymispair signals
18060 J. Biol. Chem. (2018) 293(47) 18055–18070
tration and showed nomore than 0.86 complex bound permis-
paired DNAmolecule at 0.1 and 2.5 mMATP, respectively (Fig.
4D), consistent with previous results indicating that this com-
plex cannot efficiently form sliding clamps (30). Like Msh2–
Msh6(G1142D), steady-state binding of the Walker A Lys
mutantMsh2–Msh6 complexes was largely insensitive to ATP,
although binding was highest at the highest ATP concentration
tested (2.5mM). TheMsh2-LysmutantMsh2–Msh6 complexes
had a maximum binding of 1 Msh2–Msh6 complexes per
mispaired DNA molecule, whereas the Msh6-Lys mutant
Msh2–Msh6 complexes had a maximum binding of up to 1.4
Msh2-Msh6 complexes bound permispairedDNA (Fig. 4,A,B,
and C).
We then analyzed the dissociation ofMsh2–Msh6 after addi-
tion of 1mM IPTG to release the LacI end block. The half-life of
the major component of dissociation for WT Msh2–Msh6 in
the presence of ATP was found to be 3.9 	 0.1 s (see “Experi-
mental procedures”). We therefore measured the percentage
of dissociation of this rapid component by comparing the
response units before and after adding IPTG. The postaddition
time point was 200 s, which corresponded to10 half-lives. In
the absence of ATP, WT Msh2–Msh6 was insensitive to the
addition of IPTG (2.4% dissociation), but showed dramatically
increased dissociation at different ATP concentrations (Fig.
4D). In contrast, Msh2–Msh6(K988M), which showed some
ATP-dependent increased accumulation of double end–
blocked mispaired DNA and some IPTG-induced rapid disso-
ciation in the presence of ATP (Fig. 4A), had reduced levels of
dissociation at all ATP concentrations below the maximum
concentration tested (2.5 mM ATP; Fig. 4D). As a control, we
examined the Msh2–Msh6(G1142D) dominant mutant com-
plex that is incapable of sliding clamp formation (21, 30, 51, 52)
and found that the dissociation upon addition of IPTG was
unaffected by addition of ATP. Most of the Walker A Lys
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Figure 3. Analysis of Msh2–Msh6-mispair binding in the absence of nucleotide. A, representative SPR sensorgrams showing WT Msh2–Msh6 or Msh2–
Msh6(K988M) binding tomispaired (T; blue) or base-paired (GC; green) DNA in the absence of ATP. B, plot of the percentage of WTMsh2–Msh6 steady-state
response (RUmax) for the T mispair–containing substrate (left, blue) and the GC fully base-paired control substrate (right, green); the level of binding was
normalized to theWT level of binding, whichwas set at 100%. In all cases, the R2 values for the fits to determine RUmaxwere above 0.993, and inmost cases, the
R2 values for the fits were above 0.999. Error bars represent the S.D. from themean, and individual values from different experiments are indicated by the dots
on each histogram bar.
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Figure 4. Msh2 andMsh6mutants havemispair binding defects in the presence of ATP and are affected by ATP differentially fromWTMsh2–Msh6.
A, representative sensorgram showing substantial or little sliding clamp formation by WT Msh2–Msh6, Msh2(K694M)–Msh6, and Msh2–Msh6(K988M) onT
mispair–containing substrate (blue) but little sliding clamp formation on fully base-paired substrate (green). Msh2–Msh6 was added at 10 s, and IPTG was
added at 160 s. B, fitted steady-state response (RUmax) of WT Msh2–Msh6 (red) and Msh2–Msh6(K988M) (purple) on a T mispair–containing substrate is
plotted as a function of ATP concentration. In all cases, fits to the association curves had R2 values greater than 0.996. C, the molar ratio of Msh2–Msh6
complexes to DNA at steady state (RUmax) was calculated for WT and mutant Msh2–Msh6 complexes at different ATP concentrations. In all cases, fits to the
association curves had R2 values greater than 0.996. D, the percentage of Msh2–Msh6 dissociation for WT Msh2–Msh6 (red) and Msh2–Msh6(K988M) (purple)
at 200 s (corresponding to 40 s or 
10 half-lives for the WT sliding clamp after the addition of IPTG) is plotted as a function of ATP concentration. E, the
percentage of Msh2–Msh6 dissociation was determined for WT and mutant Msh2–Msh6 complexes at different ATP concentrations. In C and E, individual
values from different experiments are indicated by the dots on each histogram bar.
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mutantMsh2–Msh6 complexes showed little or no evidence of
IPTG-induced dissociation in the presence of ATP. In contrast,
the low (compared with WT Msh2–Msh6; Fig. 4A) amount of
Msh2–Msh6(K988M) complex that accumulated on double
end–blocked mispaired DNA in the presence of ATP showed
IPTG-induced dissociation (Fig. 4, A, D, and E). Overall, the
results of the two types of experiments are consistent with the
view that the Walker A Lys mutant Msh2–Msh6 complexes
bind mispairs and either do not form ATP-induced sliding
clamps that ultimately accumulate on themispairedDNAor, in
the case of the Msh2–Msh6(K988M) mutant complex, form a
significantly reduced level of sliding clamps. These results are
consistent with previous observations that the limited number
of S. cerevisiae Walker A and B motif Msh2–Msh6 mutant
complexes analyzed showed normal mispair binding in the
absence of nucleotides in gel shift and filter binding assays and
bound to mispairs in these assays in the presence of ATP (28,
46, 47, 49, 50). We note that the human Walker A Lys to Ala
mutant MSH2–MSH6 complexes showed that the mutant
MSH2–MSH6 complexes also displayed sliding clamp defects
although not as striking as the defects seen here (37).
Walker A LysmutantMsh2–Msh6 complexes show reduced
direct dissociation
Msh2–Msh6 complexes can directly dissociate from mis-
paired DNA in addition to sliding off the ends of the DNA.We
tested direct dissociation of mispair-bound Msh2–Msh6 using
the 236-bp biotin-streptavidin and lacO-LacI double end–
blocked substrate, which eliminates the faster end-dependent
dissociation of sliding clamps. Msh2–Msh6 was first bound to
the DNA in buffer containing ATP and LacI. Buffer flow was
then switched to buffer containing ATP and LacI but lacking
Msh2–Msh6. WT Msh2–Msh6 showed a faster dissociation
from the DNA than the Walker A Lys mutant Msh2–Msh6
complexes and the Msh2–Msh6(G1142D) complex (Fig. 5).
The dissociation curves were fit (see “Experimental proce-
dures”), and the major component of the dissociation of WT
Msh2–Msh6had a half-life of 45.3 s, whichwas 11.6-fold slower
than the end-dependent dissociation of WT Msh2–Msh6 (3.9
s). In contrast, the half-lives the major component of dissocia-
tion of the Msh2–Msh6(G1142D) complex and the Walker A
Lys mutant Msh2–Msh6 complexes were substantially longer,
ranging from165 to 294 s (Fig. 5B).We also examined the direct
dissociation of WT Msh2–Msh6 in the absence of nucleotide,
conditions where Msh2–Msh6 binds mispairs but does not
form sliding clamps; under these conditions, themajor compo-
nent of dissociation of the WT Msh2–Msh6 complex had a
half-time of dissociation of 740 s. These results are consistent
with the idea that themispair-bound complexes aremore stably
associated with DNA thanMsh2–Msh6 clamps that are sliding
on DNA and are not bound to a mispair.
Walker A LysmutantMsh2–Msh6 complexes are proficient for
recruitingMlh1–Pms1
In addition to being required for the formation of Msh2–
Msh6 sliding clamps, ATP is also required for Msh2–Msh6 to
recruit Mlh1–Pms1 (22, 66–68). To monitor Mlh1–Pms1
recruitment using SPR, Msh2–Msh6 and LacI in buffer con-
taining ATP was flowed over the double end–blocked mis-
paired DNA-bound surface until binding reached steady
state, and then the buffer flow was switched to buffer con-
tainingMsh2–Msh6,Mlh1–Pms1, LacI, andATP;Mlh1–Pms1
recruitment was observed as an increase in RU relative to the
steady-state level of Msh2–Msh6 binding alone (Fig. 6A). The
increase inRUafter the addition ofMlh1–Pms1 is thought to be
due entirely to Mlh1–Pms1 and not additional Msh2–Msh6
(22), which is consistent with single-molecule studies of the
bacterial MutS and MutL homologs (36). WT Msh2–Msh6
recruitedMlh1–Pms1 to a similar extent as observed previously
(21, 22, 30, 31), and all six Walker A Lys mutant Msh2–Msh6
complexes were also able to recruit Mlh1–Pms1 (Fig. 6, A and
B). The molecular ratio for the recruitment of Mlh1–Pms1 to
WT Msh2–Msh6 was 1.07 (Fig. 6B), which is consistent with
the formation of a 1:1 complex of Mlh1–Pms1 toMsh2–Msh6.
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Figure 5. Analysis of Msh2–Msh6 directly dissociating from double end–blocked DNA. A, representative surface plasmon resonance sensorgrams
showingWT andmutant Msh2–Msh6 binding to, and directly dissociating from, mispaired DNA in the presence of ATP. Direct dissociation reactions (red and
purple curves) were performed the same as the sliding clamp formation experiments except IPTG and Msh2–Msh6 were omitted from the ATP wash step.
Consequently, any Msh2–Msh6 leaving the DNAmust do so directly due to the continual presence of the LacI end block. B, half-lives of themajor component
of dissociation ofWT andmutantMsh2–Msh6 complexes fromdouble end–blockedDNA. In all cases, fits to the dissociation curves had R2 values greater than
0.997.
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Each of the Walker A Lys mutant Msh2–Msh6 complexes
clearly bound Mlh1–Pms1 with the observed molecular ratios
ranging from 2.06 to 3.75 Mlh1–Pms1 complexes bound per
Msh2–Msh6 complex (Fig. 6B). These results indicate that the
mispair-bound Walker A Lys mutant Msh2–Msh6 complexes
are proficient for recruiting Mlh1–Pms1. However, the altered
(increased) ratio of Mlh1–Pms1 to Msh2–Msh6 seen for the
mutant Msh2–Msh6 complexes compared with WT Msh2–
Msh6 suggests that some aspect of the dynamics ofMlh1–Pms1
recruitment is altered by the Walker A Lys amino acid substi-
tutions. The ability of the Walker A Lys mutant Msh2–Msh6
complexes to recruit Mlh1–Pms1 is distinct from the proper-
ties of the previously characterized dominant MSH6 mutant
Msh2–Msh6 complexes: both types of mutant complexes bind
mispairs but do not form sliding clamps, whereas the dominant
mutant Msh2–Msh6 complexes either fail to recruit Mlh1–
Pms1 or in the case of Msh2–Msh6(G1142D) recruit much
reduced amounts of Mlh1–Pms1 (30).
Msh2 andMsh6Walker A Lysmutant complexes are partially
defective for activation of theMlh1–Pms1 endonuclease
TheMlh1–Pms1 endonuclease activity that is activated in an
Msh2–Msh6-, PCNA-, RFC-, and ATP-dependent manner is
essential for MMR in vivo and for 3 nick–directed MMR in
reconstitutedMMRreactions in vitro (53, 60, 63, 64).We exam-
ined theWalkerALysmutantMsh2–Msh6 complexes for their
ability to promote Mlh1–Pms1 endonuclease activity in an
assay containing amispairedDNA substrate with a pre-existing
3 nick at the AflIII site (Fig. 2A). The reaction products were
analyzed by linearizing the DNA with ScaI followed by alkaline
agarose gel electrophoresis and Southern blotting using a probe
that hybridizes just 3 of the diagnostic ScaI site on the 3 nick–
containing strand and reveals the position of the Mlh1–Pms1-
induced nick closest to the ScaI site (53). Consistent with pre-
vious results (53), in the presence of WT Msh2–Msh6 in
reactions containing 2.5 mM ATP,22% of the input substrate
was nicked between the ScaI and AflIII sites as revealed by a
smear of DNA fragments that were shorter than the 1.55-kb
starting fragment (Fig. 7A). In contrast, omitting Msh2–Msh6
or substituting the mispair binding–defective Msh2–Msh6
(F337A) mutant resulted in substantially less nicking byMlh1–
Pms1 (Fig. 7, A and B). TheWalker A Lys mutant Msh2–Msh6
complexes were largely functional for promoting Mlh1–Pms1
nickingwith theMsh2mutants promoting50% of the nicking
of WT Msh2–Msh6 and the Msh6 mutants promoting 60–
80% of WT activity at 2.5 mM ATP (Fig. 7, A and B). When the
ATP in the nicking assay was reduced to 0.1 mM, we observed
that all themutants showed further reduced nicking that was in
all cases, except the Msh2(K694R)–Msh6 mutant, higher than
the background level of nicking seen in the absence of Msh2–
Msh6 (Fig. 7C). These results indicate that the Walker A Lys
mutant Msh2–Msh6 complexes are at worst only partially
defective for promoting activation of the Mlh1–Pms1 endonu-
clease relative to that seen with WTMsh2–Msh6, especially at
physiological ATP concentrations (2.5 mM ATP (69, 70)).
Discussion
ATP binding and hydrolysis by theMsh2–Msh6 complex are
linked tomultiple steps inMMR (22–24, 41). Here, wemutated
the conserved Walker A motif lysine codons (Lys694 in Msh2
and Lys988 inMsh6) ofMSH2 andMSH6 to alanine, arginine, or
methionine codons and studied the mutations and resulting
mutant Msh2–Msh6 complexes in detail. All six mutations
caused ATP binding defects at one or both nucleotide-binding
sites and caused completeMMRdefects in vivo. In contrast, the
same mutant proteins were partially or largely functional in
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reconstituted MMR reactions in vitro as well as in biochemical
assays of individual MMR steps. Of all the biochemical defects
observed in vitro, the inability of the Walker A Lys mutant
Msh2–Msh6 complexes to form sliding clamps displayed the
best correlation with the complete MMR defects caused by the
Walker A Lys mutations in vivo.
Previous studies of different families of Walker A ATPases
have shown that changing the critical invariantWalker Amotif
Lys residue to alanine ormethionine often results in ATP bind-
ing defects, whereas changing the Lys residue to arginine can
causeATP hydrolysis defects (24, 56). Contrary to initial expec-
tations, UV cross-linking experiments showed that all six
Walker A Lys amino acid substitutions tested caused an ATP
binding defect at the mutated nucleotide-binding site (Fig. 1).
As a result, we did not examine the ATP hydrolysis properties
of themutantMsh2–Msh6 complexes; indeed, previous studies
of the Msh2(K694A)–Msh6 and Msh2(K694R)–Msh6 com-
plexes have shown that ATP binding defects also result in
altered ATP hydrolysis (27). These results are similar to those
observed with the human MSH2 Walker A lysine to arginine
substitution that caused a strong ATP binding defect seen by
UV cross-linking (49). The human MSH6 lysine to arginine
substitution caused a small ATP binding defect in UV cross-
linking experiments in contrast to our results (49). Interest-
ingly, two of the Msh2 mutant complexes (Msh2(K694A)–
Msh6 and Msh2(K694R)–Msh6) had ATP binding defects at
both nucleotide-binding sites, which is consistent with previ-
ous observations that nucleotide binding at one of the Msh2–
Msh6 nucleotide-binding sites can affect nucleotide binding
and hydrolysis at the other nucleotide-binding site (21, 24, 27,
55). Overall, these results suggest that the defects associated
with theWalker A LysmutantMsh2–Msh6 complexes primar-
ily reflect ATP binding defects and altered conformational
change–driven protein dynamics due to reduced ATP binding.
All of theWalkerALysmutantMsh2–Msh6 complexeswere
proficient for mispair binding and proficient for recruitment of
Mlh1–Pms1. In contrast, all six of the Walker A Lys mutant
Msh2–Msh6 complexes displayed similar biochemical defects
in three different MMR-related assays: 1) repair in 5 nick–
directed Exo1-dependentMMR (Fig. 2,B,C, andD), 2) repair in
3 nick–directed Mlh1–Pms1–dependent MMR (Fig. 2, E and
F), and 3) activation of the Mlh1–Pms1 endonuclease (Fig. 7).
The extent of the defect depended on ATP concentration with
small partial defects being observed at physiological 2.5 mM
ATP (69, 70) and stronger defects being seen at less than phys-
iological 0.1 mM ATP. At 0.1 mM ATP, all of the Walker A Lys
mutantMsh2–Msh6 complexes showed a complete defect in 5
nick–directed Exo1-dependent MMR but only a partial defect
in 3 nick–directed Exo1-independent MMR. This result sug-
gests that theWalkerALysmutantMsh2–Msh6 complexes are
unable to support excision by Exo1 at low ATP concentrations,
potentially due to defects in the recruitment of Exo1 (71–73).
Consistent with this, we have identified a mutation altering an
amino acid in theMsh2 nucleotide-binding region that causes a
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defect in Exo1-dependent MMR and causes a partial defect in
recruitment of Exo1 byMsh2 (71, 74).We have also shown that
tethering Exo1 to the Msh2–Msh6 complex to incorporate it
into the Msh2–Msh6 sliding clamp can overcome defects in
Exo1 recruitment byMsh2 (71). Together, these results suggest
that Exo1 recruitment byMsh2–Msh6may be dependent upon
ATP-induced conformational changes that occur during slid-
ing clamp formation.
We previously identified dominant mutations inMSH6 that
cause a large increase in mutation rates in frameshift reversion
assays in contrast to msh6 mutations that only cause small
increases inmutation rates in frameshift reversion assays due to
the redundancy between MSH6 and MSH3. The dominant
MSH6 mutant Msh2–Msh6 complexes bind mispairs but do
not form sliding clamps and either fail to recruitMlh1–Pms1 or
recruit reduced amounts of Mlh1–Pms1, suggesting that the
dominant mutant Msh2–Msh6 complexes bind mispairs and
then occlude Msh2–Msh3 from binding mispairs. This raises
the question of how is it that themsh6Walker A Lys mutations
are not dominant given that they result in mutantMsh2–Msh6
complexes that bind mispairs but do not form sliding clamps.
One possibility is that when mispair-bound Walker A Lys
mutant Msh2–Msh6 complexes recruit Mlh1–Pms1, the
mutant Msh2–Msh6 complexes are induced to form sliding
clamps. This would result in increased recruitment of both
Msh2–Msh6 and Mlh1–Pms1, consistent with our data, and
would then prevent the Walker A mutant Msh2–Msh6 com-
plexes fromoccludingmispairs in vivo. This would also account
for the ability of themutant complexes to largely supportMMR
in reconstituted MMR reactions and activation of the Mlh1–
Pms1 endonuclease in vitro, further implying that sliding clamp
formation is required for these activities. Testing this hypothe-
sis will likely require single-molecule analysis that is beyond the
scope of the present study (41, 73).
The ability of the mispair-boundWalker A Lys mutant com-
plexes to recruit Mlh1–Pms1 and possibly other proteins like
Exo1 appears to account for their ability to support MMR and
Mlh1–Pms1 endonuclease activation to a large extent in vitro,
especially at physiological ATP levels (69, 70). However, this
raises the question of which defect underlies the complete
MMR defect caused by theWalker A Lys mutations in vivo. All
of the Walker A Lys mutant Msh2–Msh6 complexes had
defects in sliding clamp formation, and only the Msh2–
Msh6(K988M) complex displayed any end-dependent dissoci-
ation of the bound complex, similar to WT Msh2–Msh6. The
mispair-bound Walker A Lys mutant Msh2–Msh6 complexes
also showed reduced turnover from double end–blocked mis-
paired DNA compared withWTMsh2–Msh6, which is consis-
tent withmispair-boundMsh2–Msh6 beingmore stably bound
to the mismatch than Msh2–Msh6 sliding clamps on base-
pairedDNA.One hypothesis that could explain the contrasting
observations in vivo and in vitro is that a signal amplification
mechanism in which the formation of multiple sliding clamps
on mispaired DNA, as proposed previously, is required to
recruit multiple molecules of downstream MMR factors (43,
75). This would ensure efficient MMR in vivo, which may
involvedisplacementofnucleosomesandpreventionof thepro-
cessing of replication intermediates (45, 71, 76, 77). In this
model, the inability of the Walker A mutant Msh2–Msh6
complexes to form multiple sliding clamps leads to an MMR
defect in vivo.
Experimental procedures
Strains and plasmids
S. cerevisiae strains were grown at 30 °C in either standard
YPD medium (1% yeast extract (Fisher Chemical), 2% peptone
(Fisher Chemical), and 2% dextrose (Fisher Chemical)) or the
appropriate synthetic dropout medium (0.67% yeast nitrogen
base (Difco), 2% dextrose, and 0.2% amino acid dropout mix-
ture (US Biological)) where appropriate. All S. cerevisiae strains
were derived from the S288C strain background. Escherichia
coli overexpression strains were grown at 37 °C in LB (10 g of
tryptone (Fisher Chemical), 5 g of yeast extract (Fisher Chem-
ical), and 5 g of NaCl (Fisher Chemical)/liter) supplemented
with 100 g/ml ampicillin and/or 34 g/ml chloramphenicol
where necessary. The DH5-T1 E. coli strain was used for
propagation of mutant plasmids, and the BL21 Codon (DE3)
RIL E. coli strain (Agilent Technologies) was used for protein
overexpression and purification.
The plasmid pRDK316, which is pRS316 (URA3 ARS CEN)
encoding WT MSH2, was used to create the Walker A Lys
mutations inMSH2, whereas the plasmid pRDK1227, which is
pRS315 (LEU2 ARS CEN) encoding WT MSH6, was used to
create Walker A Lys mutations in MSH6 in replicating plas-
mids. The plasmid pRDK858, which is YIp5 (URA) encoding
WT MSH2, was used to create the Walker A Lys mutations
in MSH2, whereas the plasmid pRDK1579, which is YIp5
(URA3) encodingWTMSH6, was used to create Walker A Lys
mutations in MSH6 in integrating plasmids. The plasmid
pRDK1884, which is pET11a expression vector encoding both
WT MSH2 and MSH6, was used to create the Walker A Lys
mutations inMSH2 andMSH6 for protein expression. Mutant
msh2 and msh6 mutations were created using the GeneArt
Site-Directed Mutagenesis kit (Thermo Fisher), and transfor-
mations were performed using the manufacturer’s protocol.
The YIp5-based plasmids were used in standard pop-in pop-
out protocols to replace WT MSH2 or MSH6 with different
mutant alleles, and gene deletions were made using standard
PCR-based gene deletion methods using the otherwise WT
S. cerevisiae strain RDK5964. For genetic dominance experi-
ments, pRS315- and pRS316-based plasmids were transformed
into the otherwise WT S. cerevisiae strain RDK5964. All
S. cerevisiae transformations were performed using standard
lithium acetate transformation protocols. All plasmid and
chromosomalmutant genes were sequenced in their entirety to
confirm that only the desired mutation had been introduced.
S. cerevisiae strains are listed in Table S1, and plasmids are
listed in Table S2.
Protein purification
S. cerevisiae Msh2–Msh6 (WT and mutant complexes),
Mlh1–Pms1, PCNA, RFC-1N, Exo1, and DNA polymerase 
were all overproduced and purified as described previously (58,
60); multiple batches of each protein were usually used during
the studies described. Protein preparations were greater than
95% pure when judged using Coomassie Blue staining. The
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Msh2(K694M)–Msh6 andMsh2–Msh6(K988M) protein prep-
arationswere those described previously (24). Assayswere opti-
mized for each batch of protein.
DNA substrates
The DNA substrates containing a 1 insertion mispair due
to the presence of an inserted T or creation of a GT mispair in
the nicked strand of the substrate were constructed following
previously described methods using the mutant derivatives of
pBluescript SK, pRDK1252, and pRDK1253 (58). One of the
substrates contained a single-strand break at the NaeI site 343
bp 5 to themispair, and the other substrate contained a single-
strand break at the AflIII site 442 bp 3 to the mispair. A ScaI
site 1108 bp 5 of the mispair was used along with the PstI site
that is disrupted by the mispair to diagnose repair products in
the reconstituted repair assay or to linearize the substrate for
theMlh1–Pms1 endonuclease activation assay. See Fig. 2A for a
schematic of the substrate.
The DNA substrates used for all surface plasmon resonance
experiments were 236 bp long and contained a central GTmis-
pair or1 (T) insertion for mispaired substrates or a GC bp
for homoduplex substrates. One end of each substrate had a
conjugated biotin, whereas the opposite end encoded the lacO
sequence. Substrates were prepared using a protocol published
previously (21, 22, 40, 78).
Mispair-directedMlh1–Pms1 endonuclease assay
Assays were performed essentially as described (53). Briefly,
the 40-l reactions contained 73 pmol of Msh2–Msh6 (WT or
mutant), 54 pmol of PCNA, 41 pmol of RFC-1N, 54 pmol of
Mlh1–Pms1, and 100 ng of DNA substrate andwere performed
in a buffer containing 20mMHEPES, pH 7.6, 140mMKCl, 5mM
MgCl2, 2 mM ATP, 1 mM DTT, 0.2 mg/ml BSA (Roche), 1.2%
glycerol (v/v), and 0.5mMMnSO4. After incubation at 30 °C for
30 min, reactions were stopped with addition of 30 l of stop
solution (0.35% SDS, 0.3 mg/ml Proteinase K (Sigma-Aldrich),
400 mM NaCl, 0.3 mg/ml glycogen, and 13 mM EDTA) and
incubated for 15min at 55 °C. TheDNAproducts were purified
by phenol extraction and ethanol precipitation. Purified DNA
was digested with 10 units of ScaI-HF (New England Biolabs),
and 10 ngwere run on 1%denaturing agarose gels at 25V for 3 h
and transferred to an Amersham Biosciences Hybond-N
membrane (GEHealthcare) using the capillary transfermethod
with 20 SSC buffer. DNA was cross-linked to the blot using
the autocross-link function on a Stratagene UV Stratalinker
2400, probed with a biotinylated oligo that hybridized to the
mispair-containing strand (5-ATTATCCCGTATTGACGC
CGGGCAAGAGCAACTCGGTCGCCGCATACACT) for
3 h at 55 °C in UltraHyb buffer (Invitrogen), and developed
using a Chemiluminescent Nucleic Acid Detection Module
(Thermo Scientific). Blots were scanned on a Bio-Rad Chemi-
Doc MP Imaging System, quantitation was performed using
Image Lab software, and graphs were made with GraphPad
Prism 6.
Reconstituted 3 nick–directedMMR assay
Assays were performed essentially as described (58). Reac-
tions were split into two stages. Stage 1 contained 33 mM Tris,
pH 7.6, 75 mM KCl, 2.5 or 0.1 mM ATP (as indicated in the
figures), 1.66 mM GSH, 8.3 mM MgCl2, 80 g/ml BSA, 200 M
each dNTP, 145 fmol of PCNA, 110 fmol of RFC-1N, 40 fmol
of Mlh1–Pms1, 195 fmol of the indicatedMsh2–Msh6 variant,
and 100 ng of the 3 AflIII DNA substrate in a 5-l volume.
Reactions were incubated for 10min at 30 °C. The Stage 2 reac-
tion buffer contained the same components as Stage 1 except
for the addition of 1 mM MnSO4, and the Stage 2 proteins
included 145 fmol of PCNA, 110 fmol of RFC-1N, 40 fmol of
DNA polymerase , 2.1 fmol of Exo1, 900 fmol of S. cerevisiae
replication protein A, and 195 fmol of the indicated Msh2–
Msh6 variant (note that Stage 2 did not containMlh1–Pms1) in
a 5-l volume. Stage 1 and Stage 2 reactionswere combined and
incubated at 30 °C for 2 h and then stopped by addition of 0.42
l of 0.5 M EDTA and 20 l of stop solution (360 g/ml Pro-
teinase K and 80 g/ml glycogen) followed by incubation at 30
min at 55 °C. Reactions were phenol-chloroform–extracted,
and the DNA was ethanol-precipitated followed by digestion
with PstI and ScaI. Digested DNAwas subjected to electropho-
resis on a 0.8% agarose, 1Tris acetate-EDTA gel for 45min at
100 V. Gels were imaged on an Alpha Imager HP system, and
quantitation was performed with AlphaView software.
Reconstituted 5 nick–directedMMR assay
Assays were performed essentially as described (58). The
reactions contained 33 mM Tris, pH 7.6, 75 mM KCl, 2.5 or 0.1
mM ATP (indicated in the figures), 1.66 mM GSH, 8.3 mM
MgCl2, 80 g/ml BSA, 200 M each dNTP, 145 fmol of PCNA,
110 fmol of RFC-1N, 40 fmol of Mlh1–Pms1, 195 fmol of the
indicated Msh2–Msh6 variant, and 100 ng of the 5NaeI DNA
substrate in a 10-l volume. Reactions were incubated for 2 h at
30 °C and stopped in the sameway as the 3 reconstitutedMMR
reaction. Phenol extractions, DNA precipitation, restriction
endonuclease digests, and gel electrophoresis were all per-
formed identically to the 3 reconstituted MMR reaction.
Surface plasmon resonance (Mlh1–Pms1 recruitment, sliding
clamp formation, mispair binding, and direct dissociation)
Surface plasmon resonance was performed using a Biacore
T100 instrument (GE Healthcare). All DNA substrates were
236 bp long and contained a central GT mispair, a biotin con-
jugated to one end, and the lacO sequence at the other end. For
each chip, one lane was used as a blank reference, one lane
contained20 ng (100 RU) of mispaired DNA, and one con-
tained20 ng (100 RU) of fully base-paired DNA. The ATP
concentration is indicated in the figure or 250 M where not
indicated. Where present, the ADP concentration was 250 M,
and the IPTG concentration was 1 mM. Reaction buffer con-
tained 25 mM Tris, pH 8, 4 mM MgCl2, 110 mM NaCl, 0.01%
Igepal, 2 mM DTT, and 2% glycerol. The assay setups were as
follows: sliding clamp formation: Step 1, reaction buffer with 30
mM LacI for 60 s; Step 2, reaction buffer with 50 nM Msh2–
Msh6, various concentrations of ATP, and 30 nM LacI for 150 s;
and Step 3, reaction buffer with 50 nM Msh2–Msh6, various
concentrations of ATP, 30 nMLacI for 150 s, and 1mM IPTG for
90 s. Direct dissociation experiments were exactly the same
except Msh2–Msh6 and IPTG were omitted from Step 3. For
Mlh1–Pms1 recruitment experiments, the assays were set up as
Msh2–Msh6 sliding clamps amplifymispair signals
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follows: Step 1, reaction buffer with 30 nM LacI for 60 s; Step 2,
reaction buffer with 20 nM Msh2–Msh6, 250 M ATP, and 30
nM LacI for 100 s; and Step 3, reaction buffer with 20 nMMsh2–
Msh6, 250 M ATP, 30 nM LacI, and 40 nM Mlh1–Pms1 for
300 s. Experiments were performed at 10 °C with a 20 l/min
flow rate, and data were collected at a frequency of 10 Hz.
BiaEvaluation v3.1 and Prism 6 were used to evaluate data.
The steady-state maximum for the association curves
(RUmax) of Msh2–Msh6 binding to DNA was determined by
fitting the equation RU(t) RUmax [1 f1 exp(k1 (t t0))
(1 f1) exp(k2 (t t0))] or RU(t) RUmax[1 exp(k (t
t0))] depending on whether the association showed biphasic or
monophasic behavior. In these equations, only RUmax and t0,
the initial time of injection, were taken to have direct physical
meaning. Dissociation of Msh2–Msh6 sliding clamps from
unblocked DNAs was fit to the equation RU(t)  B  (A 
B)[(f1/(f1  f2  f3)) exp(k1(t  t0))  (f2/(f1  f2  f3))
exp(k2(t t0)) (f3/(f1 f2 f3)) exp(k3(t t0))] where A
and B corresponds to the steady-state response. Direct dissoci-
ation of Msh2–Msh6 from double end–blocked DNAs was fit
to the equation RU(t) B (A B)[f1 exp(k1(t t0)) (1
f1) exp(k2(t  t0))]. The Mlh1–Pms1 recruitment experi-
ments were fit with the equation RU(t)  A(t) if t  t1 and
A(t)  B(t) if t  t1. A(t) is the association of Msh2–Msh6,
which starts at the injection start time t0; either A(t)  Amax
[1 f1 exp(k1(t t0)) (1 f1) exp(k2(t t0))] or A(t)
Amax [1  exp(k1(t  t0))]. B(t) is the association of Mlh1–
Pms1, which starts at the injection start time t1; B(t)  Bmax
[1 exp(k3(t t1))]. Molar ratios of associated Mlh1–Pms1
to Msh2–Msh6 were calculated by (Bmax/MWMlh1–Pms1)/
(Amax/MWMsh2–Msh6) where MWMlh1–Pms1 is the molecular
weight of Mlh1–Pms1 and MWMsh2–Msh6 is the molecular
weight of Msh2–Msh6.
ATP binding assay
Assays were performed essentially as described (24) and con-
tained differing amounts of ATP andMsh2–Msh6 for the high-
and low-ATP conditions. The 20-l reaction buffer contained
50 mM Tris, pH 8, 110 mM NaCl, 2 mM DTT, 0.1 mg/ml BSA
(Roche Applied Science), 0.5 mM EDTA, and 5% glycerol (v/v).
The low-ATP condition contained 0.4 pmol of Msh2–Msh6
and 1MATPwith a radiolabeled to unlabeled ratio of 1:6. The
high-ATP condition contained 4 pmol of Msh2–Msh6 and 60
M ATP with a radiolabeled to unlabeled ratio of 1:31. Reac-
tions were incubated for 10 min on ice and cross-linking on ice
for 20 min in a UV Stratalinker 2400 machine (approximately
5.52 J/cm2 total; Stratagene). Laemmli buffer was added to a 1
concentration, and the samples were incubated for 10 min at
95 °C and subjected to 4–15% SDS-PAGE for 1 h at 200 V. Gels
were exposed to phosphorimaging screens and scanned on a
Bio-Rad Personal Molecular Imager.
Determination ofmutation rates
Mutation rates were determined by fluctuation analysis (79)
using the hom3–10 and lys2–10A frameshift reversion assays
and the CAN1 forward mutation assay and were performed as
described (12, 72, 80). Seven single colonies for each of two
separate isolates (14 single colonies total) of the same strain
were isolated fromYPD plates whenmutations were integrated
onto the chromosome and used to inoculate 10-ml YPD cul-
tures that were grown overnight at 30 °C with shaking. Appro-
priate dilutions were then plated onto YPD, synthetic complete
(SC) lysine, SC threonine, or SC arginine canavanine
(60 mg/liter canavanine) media. The resulting colonies were
counted after growth at 30 °C for 3 days, and the median muta-
tion rate was calculated for each strain.
Dominance of Walker A Lys mutations was assessed using
semiquantitative patch tests (12, 81). S. cerevisiae strain
RDKY5964 harboring ARS CEN plasmids encoding mutant
versions of msh2 or msh6 (Table S2) were grown on Ura
(msh2 mutations) or Leu (msh6 mutations) plates to obtain
single colonies, which were then patched onto the same
medium and after growth replica-plated onto Ura or Leu
plates that were in additionThr,Lys, orArgcanavanine
(60 mg/liter canavanine) to test for growth of papillae.
Increased papillae in a patch signified genetic dominance of the
mutant allele. The msh6-S1036P mutation is a known domi-
nant mutation and was used as a positive control.
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